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Transient receptor potential vanilloid1 (TRPV1) and glutamate receptors (GluRs) are located in small diameter primary aﬀerent
neurons (nociceptors), and it was speculated that glutamate released in the peripheral tissue in response to activation of TRPV1
might activate nociceptors retrogradely. But, it was not clear which types of GluRs are functioning in the nociceptive sensory
transmission. In the present study, we examined the c-Fos expression in spinal cord dorsal horn following injection of drugs
associatedwithglutamatereceptorswith/withoutcapsaicinintothehindpaw.Thesubcutaneousinjectionofcapsaicinorglutamate
remarkably evoked c-Fos expression in ipsilateral sides of spinal cord dorsal horn. This capsaicin evoked increase of c-Fos
expression was signiﬁcantly prevented by concomitant administration of MK801, CNQX, and CPCCOEt. On the other hand,
there were not any signiﬁcant changes in coinjection of capsaicin and MCCG or MSOP. These results reveal that the activation of
iGluRsandgroupImGluRinperipheralaﬀerentnervesplayanimportantroleinmechanismswherebycapsaicinevokes/maintains
nociceptive responses.
1.Introduction
Glutamate which is a major excitatory neurotransmitter in
the central nervous system has been shown recently to play
animportantroleinperipheralnociceptivetransmission[1].
Concerning the existence of glutamate in the small-diameter
aﬀerentﬁbers,ithasbeenreportedthatelectricalstimulation
of the sciatic nerve or noxious heat stimulation (50◦C)
caused an increase of the glutamate level in subcutaneous
perfusate [2, 3].
Glutamate receptors (GluRs) are classiﬁed into iono-
tropic GluRs (iGluRs: NMDA, AMPA/kainate receptor) and
metabotropic GluRs (mGluRs: group I, II, and III mGlu
r e c e p t o r ) .T h e r ei se v i d e n c et h a tb o t hi G l u R s[ 4]a n d
mGluRs [5] have been located in the peripheral processes of
primary unmyelinated aﬀerents. In this connection, electron
microscope studies demonstrate that GluRs are transported
from the DRG cell bodies into central and/or peripheral
primary aﬀerent terminals [6]. NMDA, AMPA, and kainate
receptors (NMDA/AMPA-kainate receptors) are localized on
unmyelinated axons at the dermal-epidermal junction in the
glabrous and hairy skin of rats [7, 8]a n dh u m a nh a i r y
skin [9]. The immunostain labeled unmyelinated ﬁbers are
assumed to be sensory ﬁbers and not sympathetic eﬀerents
that are also unmyelinated.
Besides these anatomical data, behavioral evidences sup-
port a role for peripheral GluRs in normal nociceptive trans-
mission. Intraplantar injection of L-glutamate or iGluR ag-
onists into the hindpaw evokes thermal and mechanical
hyperalgesia and allodynia, which can be blocked by appro-
priate antagonists [7, 10–12].
Transient receptor potential Vanilloid 1 (TRPV1) is also
located in small- and medium-sized dorsal root ganglion
(DRG) neurons. A broad range of stimuli such as noxious2 Pain Research and Treatment
heat, protons, lipid-derived endovanilloids, and inﬂamma-
tory mediators either directly activate or modulate TRPV1
[13, 14], and stimulation of TRPV1 elicits the release of
glutamate[12,15,16].Attheperipheralterminalsofprimary
aﬀerents, TRPV1-mediated Ca2+ inﬂux triggers the release of
neuropeptides and neurotransmitters, which is responsible
for nociceptive processing [14]. TRPV1-expressing dorsal
horn neurons in the spinal cord are revealed to be gluta-
matergic [17].
With regard to the interaction between TRPV1 and
GluRs, there is some evidence supporting the modulation
of TRPV1 function through GluRs. For example, group I
mGluRs (especially mGluR5) are expressed together with
TRPV1 in DRG neuron and increase thermal sensitivity
by enhancing TRPV1 function at peripheral endings and
central presynaptic terminals of nociceptors [18, 19]. Group
II mGluRs are also coexpressed with TRPV1 and activation
of mGluRs can inhibit nociceptive transmission induced by
TRPV1 activation [20]. Furthermore, it was reported that
the activation of peripheral iGluRs (NMDA receptors) may
be important in the mechanisms whereby capsaicin evokes
nociceptive trigeminal responses [21].
We also observed that GluRs, in particular, iGluRs and
group I mGluR existing in peripheral endings of capsaicin-
sensitive aﬀerent ﬁbers, play an important role in the
development and maintenance of hyperalgesia following
excitation of TRPV1 by determining the changes of gluta-
mate levels in the extracellular space of rat hindpaw and pain
behavior in the thermal withdrawal latency [12].
In this study, we are examining c-Fos levels concerning
theneuralactivityinthespinalcordinresponsetoperipheral
activation of TRPV1, GluRs, or both in an attempt to see
which GluRs drive highest levels of activity.
2.MaterialsandMethods
2.1. Experimental Procedures. A l ls u r g i c a la n de x p e r i m e n t a l
procedures for animals were reviewed and approved by the
Osaka University Faculty of Dentistry and the Ohu Uni-
versity Intramural Animal Care and Use Committees, and
conformed to the guidelines of the International Association
for the Study of Pain [14].
Adult male Sprague Dawley rats weighing 200g–300g
(CLEA Japan, Inc. Tokyo) were used in all experiments. Rats
were kept in a 12h light/dark cycle and received food and
water ad libitum.
2.2. Drug Administration. While animals were inside the
small cage, drugs were administrated subcutaneously (s.c.)
into the left hindpaw.
Drugs were administered in the volume of 50μL, s.c.,
into the plantar surface of the left hindpaw using a 100μL
Hamilton syringe (Reno, Nev, USA) with a 30-gauge needle
without anesthesia when animals were kept in a small cage
to hold them. The needle was inserted into the plantar
skin proximal to the midpoint of the hindpaw. The applied
concentrations of L-glutamate and GluR antagonists were
decidedbasedontheresultobtainedfromthepreviousstudy
[12].
2.3. c-Fos Immunohistochemistry. Fos immunoreactivity (la-
beled nuclei of Fos-immunoreactive spinal neurons) ipsi-
and contralateral to the stimulated side was detected accord-
ing to a standard avidin–biotin–peroxidase technique [18,
22]. Brieﬂy, two hours after the drug injection, animals were
deeplyanesthetizedwithsodium-pentobarbitalandperfused
transcardiallywith100mLof0.9%salinefollowedby500mL
of 4% paraformaldehyde in 0.1M phosphate buﬀer (PB; pH
7.4) and the spinal cord was taken out, postﬁxed in the
same ﬁxative overnight at 4◦C, and then immersed into 20%
sucrose in 0.1M PB at 4◦C until it sank. Serial transverse
60–80μm thick sections at L4-L6 were cut using a freezing
microtomeandcollectedin0.02Mphosphatebuﬀeredsaline
(PBS). Sections were washed in PBS for 30min and blocked
with 1% normal goat serum for 30min and then incubated
in a rabbit antibody against c-Fos (1:7000 dilution; Santa
Cruz Biotech, Santa Cruz, Calif, USA) for 60min in room
temperature and then for 12h at 4◦C. After washing in
PBS for 30min, sections were incubated in biotinylated goat
antirabbitantiserum,andwashedinPBSfor30minandthen
immunohistochemically stained for 60min using avidin-
biotin-peroxidase complex (Vectastain, Vector Laboratories,
Burlingame, Calif, USA). To visualize peroxidase activity,
sections were immersed in 0.05% diaminobenzidine tetrahy-
drochloride, 0.1% ammonium nickel sulfate, and 0.01%
hydrogen peroxide in 0.05M Tris-HCl buﬀer (pH 7.2).
Sections were washed in PBS for 30min and then mounted
on gelatin-coated slides, air-dried, and coverslipped.
2.4. Quantiﬁcation of Number of c-Fos-Immunoreactive (ir)
Cells. c-Fos-ir cells of laminae I-II and laminae III-IV of all
sections (about 80–100) were counted in accordance with
previously described methods [23]. In brief, among them,
the best labeled 10 sections of the spinal cord segments from
L4–L6werechosenforthemeannumberpercertainsegment
of labeled neurons.
Our quantiﬁcation dealt only with the number and
location of cell proﬁles with histologically detectable Fos
immunoreactivity,wheretheintensityofpositivecellproﬁles
was not considered. The number of c-Fos-ir cell proﬁles in
the spinal cord dorsal horn was counted only in laminae I-
II and laminae III-IV, respectively, according to the method
by which the dorsal horn was separated into two areas
as follows: the lateral one-fourth of laminae I-II that is
referred to as the posterior cutaneous (PC) territory in
conjunction with the medial three-fourth of laminae I-II
that corresponds to the terminal ﬁeld of C ﬁbers of primary
neurons innervating the sciatic nerve, and laminae III-IV
that is the terminal ﬁeld of Aβ ﬁbers of primary neurons,
[24, 25]. In all these tests, a double blind procedure was used
to prevent the observers from knowing the experimental
groups.
2.5.DrugPreparation. WeusedL-glutamateasGluRagonist.
As GluR antagonists, the following drugs were used: selective
noncompetitive NMDA-receptor antagonist, (5S,10R)-
(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-
5,10-imine hydrogen maleate [(+)-MK-801 hydrogenPain Research and Treatment 3
Table 1: Mean value of c-Fos-ir cells in the dorsal horn of L4-L5 2h after s.c. injection of capsaicin, glutamate, and glutamate receptors
antagonists with/without capsaicin. The value in each group was represented mean ± SEM obtained from at least 10 animals, and the
diﬀerence of the means was analyzed with the Student’s t-test.
Group Ipsilateral Contralateral
I/II-layer III\IV-layer I/II-layer III\IV-layer
Vehicle 60 ± 52 2 ± 81 2 ± 47 ± 2
Capsaicin(cap) 489 ± 34∗ 63 ± 18 44 ±13 20 ±9
Glutamate 283 ± 18∗ 36 ± 51 9 ± 81 2 ±6
MK801 79 ± 31 1 ± 73 3 ± 12 9 ± 5
CNQX 70 ± 87 ± 31 4 ± 73 ± 2
CPCCOEt 59 ± 86 ± 31 0 ± 46 ± 2
MCCG 63 ± 10 5 ± 22 8 ± 11 5 ± 2
MSOP 66 ± 16 5 ± 39 ± 45 ± 3
Cap + MK801 227 ± 32# 14 ± 48 ± 63 ± 2
Cap + CNQX 205 ± 40# 11 ± 72 2 ± 12 3 ± 2
Cap + CPCCOEt 236 ± 58# 17 ± 11 12 ± 74 ± 3
Cap + MCCG 560 ± 85 27 ± 10 24 ± 93 ± 1
Cap + MSOP 383 ± 21 22 ± 31 8 ± 13 4 ± 1
∗Signiﬁcant diﬀerence at P<0.05 between vehicle and capsaicin, or glutamate-treated group. #Signiﬁcant diﬀerence at P < 0.05 between capsaicin and
capsaicin + MK801, or capsaicin + CNQX, or capsaicin + CPCCOEt-treated group.
maleate]; competitive kainite/AMPA-receptor antagonist,
6-cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX);
group I mGluR selective noncompetitive mGlu1R antag-
onist, 7-(hydroxyimino) cyclopropa[b]chromen-1a-carbox-
ylate ethyl ester (CPCCOEt); group II mGluR antago-
nist, (2S,3S,4S)-2-methyl-2-(carboxycyclopropyl)glycine
(MCCG); selective group III mGluR antagonist, (R,S)-a-
methylserine-O-phoephate (MSOP). These agonist and ant-
agonists of the GluR were obtained from Tocris (Ball-
win, MO, USA). 8-Methyl-N-vanillyl-6-noneamide (cap-
saicin) and N-[2-(4-chlorophenyl)ethyl]-1,3,4,5-tetrahydro-
7,8-dihydroxy-2H-2benzazepine-2-carbothio-amide (cap-
sazepine) were obtained from Sigma Chemical Co. (St.
Louis, MO, USA), and Cayman Chemical (Ann Arbor, MI,
USA), respectively. All the other chemicals were obtained
from Wako Pure Chemical Industries, Ltd. (Osaka).
In accordance with the product material safety data
sheets, L-glutamate was diluted in NaOH; MK801, MCCG,
andMSOPweredilutedinwater.CNQXandCPCCOEt were
diluted in dimethyl sulfoxide. The other drugs except for
these were dissolved in saline. Capsaicin (Cap) was prepared
as a 3mM solution in saline containing 10% ethanol and
10% Tween 80. The pHs of all solutions were adjusted to 7.4.
2.6. Statistical Analysis. Statistical analysis of c-Fos-ir cells
was performed by Student’s t-test for unpaired values. All
data was presented as a mean ± SEM. P values less than 0.05
or 0.01 were considered to indicate statistical signiﬁcance.
3. Results
3.1. Time Course of Number of c-Fos-ir Cells in L4-L5 Spinal
Dorsal Horn after Intraplantar Injection of Saline. Immu-
noreactivity for c-Fos appeared gray to black and homoge-
neously labeled the oval or roundish nucleus of cells in spinal
dorsal horn at L5 (Figures 1, 5,a n d6). In the intact animals,
the basal level of c-Fos expression on the both sides of the
lumbar spinal cord (L4-L5) was very low (zero or one c-
Fos-ir cell per 60–80μm thick section), which was referred
to as pretreatment value (pre). In animals administered with
vehicle,c-Fos-ircellswererarelydistributedeitherinlaminae
I/II (60 ± 5) or in laminae III/IV (22 ± 8) on the ipsilateral
side or on the contralateral side (I/II, 12 ± 4; III/IV, 7 ± 2)
(Figure 2, Table 1).
3.2. Capsaicin- and Glutamate-Induced c-Fos Expression. In
all the experimental tests with injection of capsaicin (3mM)
or glutamate (100mM), the maximum number of labeled
cells occurred consistently in laminae I and II (I/II) of the
spinal dorsal horn on the ipsilateral side.
The maximum number of c-Fos-ir cells (400–500)
evoked by capsaicin was observed in laminae I/II on the
ipsilateral side 1h–3h after injection, and much smaller
number of c-Fos-ir cells (<100) occurred in laminae III
and IV. This remarkable increase in laminae I/II on the
ipsilateral side was maintained for more than 6h. However,
there was no diﬀerence between the numbers of c-Fos-ir
cells in III/IV on the ipsilateral side and, that in laminae I/II
and III/IV on the contralateral side at any measuring time
(Figure 3, Table 1).
In glutamate-treated animals, the increase of c-Fos-ir
cells began 15min after injection in laminae I/II on the
ipsilateral side, and continued for 4 hours. The maximum
number was observed (283 ± 18) 2h after injection. The
glutamate-induced c-Fos expression in laminae I/II and
laminaeIII/IVontheipsilateralsidewaslowerthanthatwith
capsaicin. The numbers of c-Fos-immunopositive cells on
the contralateral side was modest either with capsaicin (I/II,
44 ±13;III/IV,20 ±9)orglutamate(I/II,19 ±8;III/IV,12 ±
6)ateachpeaktimeontheipsilateralside(Figure 4, Table 1).4 Pain Research and Treatment
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Figure 1: Photomicrographs showing saline-induced (a), (b) and glutamate-induced c-Fos-immunoreactive (ir) cells (c), (d) in the dorsal
horn of L5 2h after s.c. injection. (a) and (c) ipsilateral side. (b) and (d) contralateral side. Solid line indicates 100μm.
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Figure 2: Time course of number of c-Fos-ir cells in the dorsal horn of L4-L5 after s.c. injection of saline. All data presented are mean ±
SEM obtained from six animals.Pain Research and Treatment 5
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Figure 3: Time course of number of c-Fos-ir cells in the dorsal horn of L4-L5 after s.c. injection of capsaicin (3mM). All data presented are
mean ± SEM obtained from six animals.
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Figure 4: Time course of number of c-Fos-ir cells in the dorsal horn of L4-L5 after s.c. injection of glutamate. All data presented are mean
± SEM obtained from six animals.6 Pain Research and Treatment
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Figure 5: Photomicrographs showing capsaicin-induced c-Fos-ir cells in the dorsal horn of L5 2h after s.c. injection of capsaicin alone (a),
(b), or combined with MK801 ((c), 1mM) or with CNQX ((d), 1mM). All data presented are mean ± SEM obtained from six animals. (a),
(c), and (d) ipsilateral side. (b) contralateral side. Solid line indicates 100μm.
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Figure 6: Photomicrographs showing capsaicin-induced c-Fos-ir cells in the dorsal horn of L5 h after s.c. injection of capsaicin alone (a),
combinedwithCPCCOEt((b),5mM),withMCCG((c),5mM),andwithMSOP((d),5mM).Alldatapresentedaremean ±SEMobtained
from six animals. (a), (b), (c), and (d) ipsilateral side. Solid line indicates 100μm.Pain Research and Treatment 7
3.3. Eﬀects of iGluRs Antagonists on the Capsaicin-Induced
c-Fos Expression. To investigate which types of GluRs were
involved in the peripheral mechanisms whereby capsaicin
evokes/maintains nociceptive responses, the eﬀects of GluRs
antagonists on the capsaicin-induced c-Fos expression were
examined at 2h after treatment, because the maximum
number of labeled cells was observed 1h–3h after capsaicin
injection.
Few c-Fos-ir cells were found in laminae I/II and
laminae III/IV of the ipsilateral dorsal horn after each single
injection ofionotropic glutamatereceptors antagonists;MK-
801 (1mM) (I/II, 79 ± 3; III/IV, 11 ± 7) or CNQX (1mM)
(I/II, 70 ± 8; III/IV, 7 ± 3), similar to vehicle injection (I/II,
60 ± 5; III/IV, 22 ± 8). The numbers of capsaicin-induced
c-Fos-ir cells in laminae I/II (489 ± 34), but not in laminae
III/IV (63 ± 18), were signiﬁcantly decreased, when MK801
and CNQX were injected with capsaicin (Cap + MK801, I/II,
227±32,III/IV,14±4,Cap+CNQX,I/II,205±40,III/IV,and
11±7)(Figure 5,Table 1).Thenumbersofcapsaicin-induced
c-Fos-ir cells on the contralateral sides did not signiﬁcantly
change by any of drugs with/without capsaicin.
3.4. Eﬀects of mGluRs Antagonists on Capsaicin-Induced c-
Fos Expression. Few c-Fos-ir cells in the ipsilateral laminae
I/II and III/IV, and fewer cells in the contralateral sides,
were observed with single injection of CPCCOEt (5mM)
(I/II,5 9 ±8, III/IV,1 ±1), MCCG (5mM) (I/II, 63 ±10,
III/IV, 3±2), and MSOP (5mM) (I/II, 66±16, III/IV, 5±3).
Coinjection of CPCCOEt with capsaicin (Cap + CPCCOEt)
signiﬁcantly decreased the number of capsaicin-induced c-
Fos-ir cells in the ipsilateral laminae I/II (236 ± 58), but
not in laminae III/IV and contralateral laminae I/II and
III/IV. There was no signiﬁcant change in the number of
c-Fos-ir cells in the ipsilateral laminae I/II, and III/IV by
injection ofMCCG combinedwithcapsaicin(Cap+ MCCG;
I/II, 560 ± 85, III/IV, 27 ± 10) or by injection of MSOP
combinedwithcapsaicin(Cap+MSOP;I/II,383±21,III/IV,
22±3)comparedtosingleinjectionofcapsaicin,respectively
(Figure 6, Table 1).
4. Discussion
It has been previously reported that glutamate was released
peripherallybyelectricalstimulationofthesciaticnerve,heat
stimulation (50◦C), or local application of capsaicin cream
to the hind instep [2, 3]. High-dose repeated pretreatment
with capsaicin leading to desensitization of small-diameter
sensory neurons (nociceptors) [26–32], signiﬁcantly attenu-
ated the glutamate release.
Capsaicin signiﬁcantly decreased thermal withdrawal
latency to irradiation [12]. These eﬀects of capsaicin were
inhibited by not only pretreatment with capsazepine, but
also coinjection of capsaicin with GluR antagonists (iGluRs
and group I mGluR). These results suggest that glutamate
is released from the peripheral endings of nociceptors by
TRPV1activation.SinceDRGcellsaswellastheircentraland
peripheral terminals express iGluRs (NMDA, AMPA/kainate
receptor) and mGluRs (group I, II, and III mGluRs) [4–
9, 17], released glutamate could activate peripheral iGluRs
and group I mGluR in development and/or maintenance of
nociception.
Inthepresentstudy,weexaminedthec-Fosexpressionas
indicator of neuronal activity by pharmacological approach.
To clarify the contribution of peripheral GluRs in develop-
ment and/or maintenance of nociception, L4-L5 spinal dor-
sal horn neuronal activity, induced by intraplantar injection
of drugs associated with glutamate receptors with/without
capsaicin into the hindpaw, was investigated.
The subcutaneous injection of capsaicin or glutamate
remarkably evoked c-Fos expression in ipsilateral sides of
spinal cord dorsal horn and the maximum number of
labeled cells occurred consistently in laminae I and II
(I/II) of the spinal dorsal horn, where small-diameter DRG
neurons terminate. The number of capsaicin-evoked c-Fos-
immunoreactive (ir) cells was about twice as much as glu-
tamate induced. A subset of capsaicin-sensitive nociceptors
might express GluRs at the peripheral endings.
This capsaicin-evoked increase of c-Fos expression was
signiﬁcantly prevented by concomitant administration of
MK801, CNQX, and CPCCOEt. These results were in agree-
ment with the ﬁndings of the behavioral pharmacology, that
is, capsaicin-induced thermal hypersensitivity was inhibited
by the injection of the antagonists such as MK801, CNQX,
or CPCCOEt in combination with capsaicin [12]. It should
be noted that approximately 50% of the capsaicin-evoked
c-Fos-ir cells were still positive, in spite of the complete
inhibition of capsaicin-induced thermal hyperalgesia caused
by injection of these antagonists [12]. On the other hand,
there were not any signiﬁcant changes in co-injection of
capsaicin and MCCG or MSOP.
In conclusion, some of the capsaicin-sensitive neurons
projected in laminae I and II (I/II) of the spinal cord
play an essential role in mechanisms whereby capsaicin
evokes/maintainsnociceptiveresponses,thoughthefunction
of the other capsaicin-sensitive neurons remained unclear.
Ionotropic glutamate receptors and/or group I mGluR at
the aﬀerent terminals of these nociceptive neurons might
be required for capsaicin-induced hyperalgesia, because
blocking them resulted in remarkable analgesia [12].
Our present study not only supports the view that GluRs
existing in peripheral3endings of capsaicin-sensitive aﬀerent
ﬁbers are involved in the development and maintenance
of hyperalgesia following excitation of TRPV1, but also
suggests the probability of development of new medicines.
Namely, the formulation of the peripheral iGluRs and group
I mGluR antagonists that do not cross the blood brain
barrier may be of potential beneﬁt by reducing peripheral
nociceptive excitability, and therefore they could provide a
new therapeutic target to pain control in the periphery.
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